Stefan Vegter
Novartis (Netherlands)(NL)
Publications by Year
Research Areas
Health Systems, Economic Evaluations, Quality of Life, Pharmaceutical Economics and Policy, Pharmaceutical studies and practices, Chronic Obstructive Pulmonary Disease (COPD) Research, Medication Adherence and Compliance
Most-Cited Works
- → Sodium Intake, ACE Inhibition, and Progression to ESRD(2011)298 cited
- → Clinical and economic impact of non-adherence in COPD: A systematic review(2013)225 cited
- → A Network Meta-Analysis of the Relative Efficacy of Treatments for Actinic Keratosis of the Face or Scalp in Europe(2014)125 cited
- → Economic Evaluations of Pharmacogenetic and Pharmacogenomic Screening Tests: A Systematic Review. Second Update of the Literature(2016)112 cited
- → Pharmacoeconomic Evaluations of Pharmacogenetic and Genomic Screening Programmes(2008)83 cited
- → Inhaled Corticosteroids and the Occurrence of Oral Candidiasis: A Prescription Sequence Symmetry Analysis(2013)80 cited
- → Improving inhaler adherence in patients with Chronic Obstructive Pulmonary Disease: a cost-effectiveness analysis(2014)71 cited
- → Misdiagnosis and mistreatment of a common side‐effect – angiotensin‐converting enzyme inhibitor‐induced cough(2009)66 cited
- → Cost–effectiveness of varicella vaccination programs: an update of the literature(2008)56 cited
- → Medication Monitoring and Optimization: A Targeted Pharmacist Program for Effective and Cost-Effective Improvement of Chronic Therapy Adherence(2014)55 cited